William Rascan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Company on brink takes psilocybin to trial for fragile X syndrome

The phase 2A trial has its detractors despite positive animal results and is being sponsored by a company that is struggling financially.

United statesUnited kingdomCity ofRush university medical centerCraig ericksonEmily osterweilMarvin hausmanElizabeth berry kravisViviana trezzaWilliam rascanEmma robinsonUniversity of edinburghHealth canadaUniversity of central floridaRoma tre universityUniversity of bristol

Nova Mentis Life Science Corp : Nova Mentis Provides Corporate Update and 2023 Outlook

Vancouver, British Columbia (Newsfile Corp. - April 5, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global leader

British columbiaUnited kingdomUnited statesMarvins hausmanDerek ivanyWilliam rascanHealth canadaCanadian securities exchangeScience incUniversity of central floridaEuropean unionResearch foundationUs drug enforcement administrationNova mentis life science corpViviana trezza at rome tre universityBritish columbia newsfile corp

Nova Mentis Life Science Corp : Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial

Vancouver, British Columbia (Newsfile Corp. - February 14, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global

City ofUnited kingdomUnited statesBritish columbiaDennis riedlNajla guthrieWilliam rascanNova mentis life science corpDigital sciencesBritish columbia newsfile corpNeither the canadian securities exchangeEuropean unionHealth canadaCanadian securities exchangeMentis life scienceControlled drugs

Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial

Nova Mentis Granted Health Canada Section 56 Exemption to Begin Psilocybin Clinical Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomUnited statesBritish columbiaNajla guthrieWilliam rascanNova mentis life science corpDigital sciencesBritish columbia newsfile corpNeither the canadian securities exchangeEuropean unionHealth canadaCanadian securities exchangeMentis life scienceControlled drugsSubstances act

Wellbeing Digital Sciences Inc says KGK subsidiary gets OK to proceed with Phase II A clinical trial assessing psilocybin therapy for fragile X syndrome

Wellbeing Digital Sciences Inc (NEO:MEDI.AQN, OTCQB:KONEF) announced that its wholly-owned subsidiary KGK Sciences Inc has received a No Objection letter .

United statesCity ofUnited kingdomNajla guthrieWilliam rascanSciences incNova mentis life science corpDigital sciencesDigital sciences incEuropean unionUs food drug administrationHealth canadaWellbeing digital sciences incNova mentis life scienceNova mentisDrug administration